our products
Contact phone

Esbriet

Respiratory Tract Esbriet (Generic) Generic drugs, marketed without brand names, contain the exact same active ingredients used in their brand-name counterparts, but cost significantly less. The drugs are required to meet US Food and Drug Administration (FDA) standards for safety, purity and effectiveness.
Esbriet

Idiopathic pulmonary fibrosis is a kind of lung illness that can be treated with the medication esbriet (pirfenidone) (IPF). Scar tissue forms deep into your lungs when you have IPF because of this. Scar tissue develops a thicker and more rigid or thicker consistency over time, which might make it more difficult for your lungs to function normally. Reduced lung function can make it difficult for a person to breathe normally.

BEST DEAL!

Save 20% with

Coupon "PKVCbYFj9G"

Pirfenidone Esbriet: A Breakthrough in Pulmonary Fibrosis Treatment

Introduction

Pulmonary fibrosis is a chronic and progressive lung disease that affects thousands of individuals worldwide. The search for effective treatments has been ongoing for years, and one medication that has shown promising results is Pirfenidone, commercially known as Esbriet. In this blog post, we will explore the benefits of Pirfenidone and its role in managing pulmonary fibrosis.

The Mechanism of Pirfenidone

Pirfenidone is a novel antifibrotic medication that works by targeting the underlying causes of pulmonary fibrosis. The exact mechanism of action is not fully understood, but it is believed to inhibit the production of certain growth factors and cytokines that contribute to the formation of scar tissue in the lungs. By doing so, Pirfenidone helps to slow down the progression of fibrosis and preserve lung function.

Clinical Efficacy of Pirfenidone

Numerous clinical trials have demonstrated the efficacy of Pirfenidone in the treatment of pulmonary fibrosis. In a landmark study published in the New England Journal of Medicine, researchers found that patients treated with Pirfenidone experienced a significant reduction in the decline of lung function compared to those on a placebo. The study also showed a decrease in the rate of disease progression and improved quality of life for patients taking Pirfenidone.

Safety and Tolerability

In addition to its effectiveness, Pirfenidone has also been shown to be generally well-tolerated by patients. Common side effects include gastrointestinal symptoms such as nausea and diarrhea, but these are usually mild and manageable. It is important for patients to discuss any potential risks and side effects with their healthcare provider before starting Pirfenidone treatment.

Conclusion

Pirfenidone, marketed as Esbriet, has emerged as a groundbreaking treatment for pulmonary fibrosis. Its ability to slow down the progression of fibrosis and preserve lung function has offered hope to patients suffering from this debilitating disease. While further research is still needed to fully understand its long-term effects, Pirfenidone represents a significant advancement in the management of pulmonary fibrosis.

Testimonials

high quality medications

Free discreet shipping

Secure online transactions

Money-back guarantee

Fast worldwide delivery

By staying on our site you automatically agree with the storage and processing of your personal data, in accordance with our Privacy Policy.